Ipamorelin is a synthetic research pentapeptide and selective agonist of the growth hormone secretagogue receptor (GHS-R). Its receptor activity has made Ipamorelin widely studied in laboratory research involving growth hormone signaling, pituitary function, neuroendocrine communication, and mechanisms associated with the growth hormone axis.

Ipamorelin research has explored its interaction with GHS-R, also known as the ghrelin receptor. Researchers have investigated how activation of this receptor participates in signaling pathways associated with pulsatile growth hormone release and communication between the hypothalamic and pituitary systems.

Another significant area of Ipamorelin research involves downstream growth hormone and insulin-like growth factor-1 (IGF-1) signaling. Laboratory studies have examined these pathways in relation to cellular metabolism, protein-related processes, tissue signaling, and biological mechanisms associated with energy regulation.

Ipamorelin has a molecular weight of approximately 711.9 g/mol and is synthetically produced for controlled research applications. It is typically supplied as a white, lyophilized powder for laboratory investigation involving GHS-R activity, growth hormone signaling, and related neuroendocrine pathways.